Journal
MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Volume 183, Issue 1, Pages 100-103Publisher
ELSEVIER
DOI: 10.1016/j.molbiopara.2012.01.006
Keywords
Malaria; Assay development; Flow cytometry
Categories
Funding
- NRSA Ruth L. Kirschstein National Research Service Award [F32 AI091129]
- Department of Defense [W81XWH-11-2-0184]
Ask authors/readers for more resources
The human malaria parasite Plasmodium falciparum causes the most deadly parasitic disease worldwide, necessitating the development of interventions that block infection. Yet, preclinical assays to measure inhibition of infection date from the 1980s and are based on microscopy. Here, we describe the development of a simple flow cytometric assay that can be used to quantitatively assess P. falciparum sporozoite infection in vitro in low and medium throughput. We demonstrate the utility of this assay for assessing both drug inhibition of infection and measuring efficacy of antibodies in blocking parasite infection. This methodology will aid in assessing functional antibody responses to vaccination and novel drugs that prevent mosquito-to-man transmission of malaria. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available